Novosanis is looking forward to join a new edition of EUROGIN from December 2 to 5 in Lisbon, Portugal. A large number of abstracts with fresh new data have been submitted. Looking forward to meeting you at our booth or at the poster sessions.
Our CEO, Vanessa Vankerckhoven, CTO, Koen Beyers and Clinical Affairs Associate, Tine Provinciael will attend the conference. Do come and talk to us to learn more on the Colli-Pee device which is suited for (home-based) volumetric collection of first-void urine allowing detection of the Human Papilloma Virus, a virus able to cause cervical cancer.